Showing 1 - 20 results of 24 for search 'N. V. Seredavkina', query time: 0.06s Refine Results
  1. 1
    27th Congress of the International Society on Thrombosis and Hemostasis

    27th Congress of the International Society on Thrombosis and Hemostasis by N. V. Seredavkina

    Published 2020-03-01
    Get full text
    Article
  2. 2
    OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS

    OSTEOPOROSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS by N V Seredavkina, Tatyana Magomedaliyevna Reshetnyak

    Published 2009-12-01
    Get full text
    Article
  3. 3
    The place of intravenous immunoglobulin in rheumatic diseases

    The place of intravenous immunoglobulin in rheumatic diseases by N. V. Seredavkina, T. M. Reshetnyak, E. L. Nasonov

    Published 2016-01-01
    Get full text
    Article
  4. 4
    ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME

    ACTOVEGIN IN THE COMPLEX THERAPY OF VASCULAR DISORDERS IN ANTIPHOSPHOLIPID SYNDROME by N V Seredavkina, D V Burenchev, T M Reshetnyak

    Published 2010-06-01
    Get full text
    Article
  5. 5
    GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

    GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS by T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov

    Published 2014-07-01
    Get full text
    Article
  6. 6
    GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS

    GLUCOCORTICOIDS IN THE THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS by T. M. Reshetnyak, N. V. Seredavkina, I. S. Dydykina, E. I. Nasonov

    Published 2014-07-01
    Get full text
    Article
  7. 7
    GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS

    GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS by N. V. Seredavkina, A. V. Smirnov, I. S. Dydykina, T. M. Reshetnyak

    Published 2014-11-01
    Get full text
    Article
  8. 8
    GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS

    GLUCOCORTICOIDS IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS: POSITIVE AND NEGATIVE ASPECTS by N. V. Seredavkina, A. V. Smirnov, I. S. Dydykina, T. M. Reshetnyak

    Published 2014-11-01
    Get full text
    Article
  9. 9
    Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antiphospholipid syndrome

    Efficacy and tolerance of selective and non-selective factor Xa inhibitors in the prevention of thrombosis in kidney disease in patients with systemic lupus erythematosus and antip... by N. V. Seredavkina, T. M. Reshetnyak, N. M. Kosheleva, A. M. Lila

    Published 2019-03-01
    Get full text
    Article
  10. 10
    Risk factors for venous thromboses in patients with rheumatoid arthritis

    Risk factors for venous thromboses in patients with rheumatoid arthritis by M. A. Satybaldyeva, T. M. Reshetnyak, N. V. Seredavkina, S. I. Glukhova, E. L. Nasonov

    Published 2019-01-01
    Get full text
    Article
  11. 11
    Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome

    Coronary atherosclerosis and cerebrovascular damage in a patient with systemi9c lupus erythematosus with antiphospholipid syndrome by N V Seredavkina, T M Reshetnyak, D V Burenchev, L V Kondratyeva, E L Nasonov

    Published 2008-06-01
    Get full text
    Article
  12. 12
    15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014)

    15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

    Published 2015-01-01
    Get full text
    Article
  13. 13
    15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014)

    15th MEDITERRANEAN RHEUMATOLOGY CONGRESS (ISTANBUL, TURKEY, 28–31 AUGUST 2014) by N. V. Seredavkina, L. N. Denisov, T. V. Korotaeva, L. V. Kondratyeva, M. V. Podryadnova

    Published 2015-03-01
    Get full text
    Article
  14. 14
    Aspergillosis in systemic lupus erythematosus

    Aspergillosis in systemic lupus erythematosus by T. M. Reshetnyak, S. G. Radenska-Lopovok, K. V. Makarov, N. V. Seredavkina, E. L. Nasonov

    Published 2016-05-01
    Get full text
    Article
  15. 15
    C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology

    C-reactive protein in antiphospholipid syndrome: relationship with cardiovascular pathology by N V Seredavkina, T M Reshetnyak, E N Alexandrova, A A Novikov, E S Mach, T V Popkova

    Published 2009-08-01
    Get full text
    Article
  16. 16
    Risk factors for venous thromboembolic events in patients with rheumatoid arthritis

    Risk factors for venous thromboembolic events in patients with rheumatoid arthritis by M. A. Satybaldyeva, T. M. Reshetnyak, N. V. Seredavkina, S. I. Glukhova, D. E. Karateev, E. L. Nasonov

    Published 2016-10-01
    Get full text
    Article
  17. 17
    VALIDATION OF A RUSSIAN-LANGUAGE VERSION OF THE VEINES-QOL/SYM QUESTIONNAIRE IN PATIENTS WITH RHEUMATIC DISEASES AND LOWER EXTREMITY CHRONIC VENOUS DISEASES

    VALIDATION OF A RUSSIAN-LANGUAGE VERSION OF THE VEINES-QOL/SYM QUESTIONNAIRE IN PATIENTS WITH RHEUMATIC DISEASES AND LOWER EXTREMITY CHRONIC VENOUS DISEASES by M. A. Satybaldyeva, N. V. Seredavkina, S. I. Glukhova, I. N. Gorskikh, T. M. Reshetnyak, E. L. Nasonov

    Published 2017-10-01
    Get full text
    Article
  18. 18
    Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range

    Effectiveness and safety of selective and non - selective factor Xa inhibitors in antiphospholipid syndrome and systemic lupus erythematosus: anti - Xa - activity range by N V Seredavkina, T M Reshetnyak, M A Satybaldyeva, L N Kashnikova, T A Temnikova, E L Nasonov

    Published 2019-05-01
    Get full text
    Article
  19. 19
    GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM

    GOMOZIGOTNAYa MUTATsIYa V GENE INGIBITORA AKTIVATORA PLAZMINOGENA 1 U PATsIENTOV S ANTIFOSFOLIPIDNYM SINDROMOM by E. V. Ostryakova, N. L. Patrusheva, A. P. Aleksankin, L. I. Patrushev, N. V. Seredavkina, E. N. Aleksandrova, A. V. Volkov, T. M. Reshetnyak

    Published 2011-06-01
    Get full text
    Article
  20. 20
    Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome

    Plasminogen activator inhibitor type 1 gene polymorphism and thromboses in patients with antiphospholipid syndrome by T M Reshetniak, E V Ostriakova, N L Patrusheva2, L I Patrushev, E N Aleksandrova, N V Seredavkina, A V Volkov, E L Nasonov

    Published 2013-01-01
    Get full text
    Article

Search Tools: